Nasdaq
CCCC
C4 Therapeutics, Inc.
- Health Care
- Listed 2020
- 1 day
- +0.6%
- 1 month
- −16.3%
- 1 year
- +85.7%
$3.64 · Mkt cap $402M
At the 6 Aug 2026 close
Nasdaq
C4 Therapeutics, Inc.
$3.64 · Mkt cap $402M
At the 6 Aug 2026 close
C4 Therapeutics, Inc. trades under the ticker CCCC on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2020. Its market capitalisation is $402M. The last closing price was $3.64, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +85.7%, and −16.3% over the past month. Returns are price returns and exclude dividends.
This page exists because CCCC is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.